Literature DB >> 31573831

Evaluation of Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnosis Clinic.

Shannon Nixon1,2, Ksenia Bezverbnaya1,2, Manjula Maganti1,2, Patrick Gullane1,2, Michael Reedijk1,2, John Kuruvilla1,2, Anca Prica1,2, Robert Kridel1,2, Vishal Kukreti1,2, Sabrina Bennett1, Patrik Rogalla2,3, Jan Delabie2,3, Melania Pintilie2,3, Michael Crump1,2.   

Abstract

PURPOSE: Lymphomas often present a diagnostic challenge, and for some a delay in diagnosis can negatively influence outcomes of therapy. We established a nurse practitioner-led lymphoma rapid diagnosis clinic (LRDC) with the goal of reducing wait times to definitive diagnosis. We examined the initial 30-month experience of the LRDC, and results were compared with time periods before implementation of the clinic to determine program impact.
METHODS: All patients referred to LRDC with suspicion of lymphoma from June 1, 2015 to Nov 30, 2017 were evaluated. Time from initial consultation to diagnosis was compared with patients diagnosed at our center with lymphoma in 2008 and 2012. Patient symptoms and relevant laboratory/imaging findings were collected to identify patterns of presentation and predictive factors for benign diagnoses.
RESULTS: Of the 126 patients evaluated, 66 (52%) had confirmation of lymphoma diagnosis. Median time to lymphoma diagnosis was 16 days for patients assessed in LRDC and 28 days for historical controls (P < .001). By univariable analysis, lymph node size greater than 3.4 cm and presence of mediastinal or abdominal adenopathy increased the likelihood of a diagnosis of malignancy, whereas younger age, being a nonsmoker, and prior rheumatologic condition were associated with a nonmalignant diagnosis. In multivariable analysis, lymph node size, age, and prior rheumatologic diagnosis remained significant.
CONCLUSION: Establishing a nurse practitioner-led LRDC was effective in shortening time to diagnosis of lymphoma. Younger age, smaller lymph node size, and prior rheumatologic disorder reduced the likelihood of a cancer diagnosis in our patient population.

Entities:  

Mesh:

Year:  2019        PMID: 31573831     DOI: 10.1200/JOP.19.00202

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN: 2688-1527


  3 in total

Review 1.  Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.

Authors:  George N Okoli; Otto L T Lam; Viraj K Reddy; Leslie Copstein; Nicole Askin; Anubha Prashad; Jennifer Stiff; Satya Rashi Khare; Robyn Leonard; Wasifa Zarin; Andrea C Tricco; Ahmed M Abou-Setta
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 2.692

2.  Differential Diagnosis of Histiocytic Necrotizing Lymphadenitis and Malignant Lymphoma with Simple Clinical Findings.

Authors:  Taichi Omachi; Naho Atsumi; Takashi Yamazoe; Sohsaku Yamanouchi; Ryosuke Matsuno; Tomoki Kitawaki; Kazunari Kaneko
Journal:  Children (Basel)       Date:  2022-02-20

3.  Prescription of Blood Lymphocyte Immunophenotyping in the Diagnosis of Lymphoid Neoplasms in Older Adults.

Authors:  Jérémie Vovelle; Céline Row; Fabrice Larosa; Julien Guy; Anca-Maria Mihai; Marc Maynadié; Jérémy Barben; Patrick Manckoundia
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.